welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Huntsman Cancer Institute study delves into reasons why preventive drug is effective
A potent preventive treatment for people at enormous risk of colorectal cancer works not only by preventing new precancerous polyps from growing, but by causing existing ones to recede, according to findings published this week by Huntsman Cancer Institute researchers.
The findings are the latest in the institute’s line of research into how to prevent colorectal cancer among the 1-in-10,000 people who inherit a condition called familial adenomatous polyposis (FAP).
“This is one little baby step in the kind of long-term goal of trying to prevent this cancer,” said Deborah Neklason, a professor of internal medicine at the University of Utah and investigator at Huntsman Cancer Institute who led the study.
expertly curated content related to this topic
-
Jejunal Cancer in Patients With Familial Adenomatous PolyposisBACKGROUND & AIMS: Familial adenoma...
-
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...Purpose: To provide recommendations on ...
-
Clinical End Points for Developing Pharmaceuticals to Manage Patients with a Sporadic or Genetic Risk of Colorectal ...To reduce the morbidity and mortality fr...
-
Inactivation of the APC Gene is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis ...PURPOSE : In adrenocortical tumors (ACT)...
-
Imatinib for Progressive and Recurrent Aggressive Fibromatosis (Desmoid Tumors): An FNCLCC/French Sarcoma Group Phas...BACKGROUND: Imatinib evaluated as a new...
-
Do NSAIDs Suppress Polyps in MUTYH-Associated Polyposis? A Case ReportPoster Presentation Background: MUTY...